Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Breast ducts: A new site for cancer treatment?

26.01.2006


Johns Hopkins Kimmel Cancer Center researchers are studying whether delivering chemotherapy drugs directly to breast "plumbing" might make treatment of early breast cancer easier on the patient and at least as good as surgery or radiation.

A report on successful tests of intraductal therapy in rats and mice published in the January 15 issue of Cancer Research has paved the way for one of the first preliminary clinical trials in women with breast cancer, currently under way in women with breast cancer scheduled for a mastectomy at Johns Hopkins.

For more than a decade, researchers have been studying how to diagnose breast cancer earlier by extracting fluid from the vast network of tiny milking-producing ducts in the breast. The idea is based on the finding that most breast cancers sprout from cells lining the milk ducts. This same idea led Kimmel Cancer Center researcher Saraswati Sukumar, Ph.D., to explore the possibility of treating early breast cancers by using hair-thin catheters to inject chemotherapy through openings at the nipple directly into the place where they started - the milk ducts.

Sukumar likens the procedure to pouring detergent down the kitchen sink to rid the pipes of unwanted material. Because early breast cancers are less likely to have escaped the ducts, intraductal therapy may have at least as good a chance to cure as radiation or surgery.



"We’d like to develop a treatment option for early breast cancers that minimizes disfigurement and spares normal tissues," says Sukumar who is the Barbara B. Rubenstein Professor of Oncology at Hopkins’ Kimmel Cancer Center.

Standard treatments for early breast cancer, called ductal carcinoma in situ (DCIS), include radiation and surgery to remove the tumor via a lumpectomy or mastectomy. Chemotherapy, reserved for disease that has spread beyond the ducts, is not typically used to treat DCIS because conventional methods of delivering the drugs through an arm or chest vein would unnecessarily send the toxic chemicals coursing throughout the entire body.

"We found that, in animal models, injecting chemotherapy into the milk ducts confines most of the drug to the breasts, leaving other tissues unharmed," says Sukumar.

Building on observations made by her lab on rat models using drugs that block estrogen, Sukumar began tests in mouse models three years ago by using a chemotherapy drug called doxorubicin. The mice were bred to develop breast cancers that were genetically similar to treatment-resistant ones in humans.

First, researchers injected mice that had palpable tumors with a slow-release formulation of low dose doxorubicin directly into their mammary ducts. At the end of the observation period, this group had tumors less than half the size of those receiving the drug intravenously. Then, the scientists increased the drug dose, and, initially, tumors in both groups remained small. But that changed when 56 days later, tumors in the IV group ballooned - almost as large as control mice getting no treatment - while tumors in the intraductal group fared much better. Eight of 10 tumors in the intraductal group disappeared in 20 days. Some of the tumors grew back, but remained small compared with the IV group. At the end of the 91-day study period, four of the 10 tumors had not come back.

Sukumar also believes that injecting chemotherapy agents or prevention drugs like tamoxifen into the breast ducts could be one option for women at high risk for the disease.

To test this premise, her team injected doxorubicin via IV or intraductally into 40 mice bred to develop breast cancer. Control mice received injections of saline or no treatment. Mice receiving IV therapy were twice as likely to develop breast cancer (32 tumors in 170 mammary glands) than those receiving a single intraductal dose (13 tumors in 196 glands). Increasing the number of intraductal injections to two per mammary gland completely protected all 10 mice (100 glands) from developing the cancer while all intravenously treated mice succumbed to the disease. The scientists found similar results using a derivative of tamoxifen in rat models.

Phase I studies in breast cancer patients have begun to test the feasibility and safety of the procedure. Among the potential side effects that Sukumar’s team, headed by Vered Stearns, M.D., breast cancer specialist at the Kimmel Cancer Center, will be studying in the trial are pain, inflammation, and changes in the structure of the duct network. Other areas for study include image-guided injections that could be rigged as "duct-detectors" to help pinpoint early lesions, as well as different chemotherapy drugs and dosing schedules.

More than 200,000 cases of breast cancer are diagnosed in the U.S. annually. DCIS accounts for 20 - 40 percent of these cases, according to researchers.

Vanessa Wasta | EurekAlert!
Further information:
http://www.jhmi.edu

More articles from Health and Medicine:

nachricht Penn study identifies new malaria parasites in wild bonobos
21.11.2017 | University of Pennsylvania School of Medicine

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>